Grifols (GRFS) Shareholder's Equity (QoQ) (2011 - 2020)

Grifols (GRFS) Shareholder's Equity (QoQ) (2011 - 2020) Analysis & Trends

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Eli Lilly	1,066.16 Bn	1,060.88 Bn	16.22 Bn
2	Johnson & Johnson	611.69 Bn	589.64 Bn	15.96 Bn
3	AbbVie	444.34 Bn	434.99 Bn	10.78 Bn
4	Astrazeneca	284.94 Bn	277.05 Bn	12.61 Bn
5	Merck	224.23 Bn	218.58 Bn	12.09 Bn
6	Amgen	195.12 Bn	183.08 Bn	5.87 Bn
7	Gilead Sciences	156.45 Bn	148.73 Bn	5.52 Bn
8	Pfizer	136.01 Bn	123.24 Bn	-1.21 Bn
9	Novartis Ag	113.45 Bn	113.67 Bn	-
10	Grifols	-	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2020	-490.01%
Mar 31, 2020	-98.26%
Jun 30, 2018	3,122.37%
Mar 31, 2018	-96.57%
Dec 31, 2016	2.21%
Sep 30, 2016	2.27%
Dec 31, 2015	1.72%
Mar 31, 2015	6.29%
Dec 31, 2014	-1.05%
Sep 30, 2014	9.87%
Jun 30, 2014	0.65%
Mar 31, 2014	6.36%
Dec 31, 2013	9.98%
Sep 30, 2013	2.82%
Jun 30, 2013	-2.04%
Mar 31, 2013	6.08%
Dec 31, 2012	5.20%
Sep 30, 2012	-1.68%
Jun 30, 2012	6.67%
Mar 31, 2012	-1.54%